EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels

Hue Vu, Evelien Peeters, Kenneth Hofkens, Katrien Vandemeulebroecke, Sara T'Sas, Charlotte Martin, Steven Ballet, Richard Hoogenboom, Steven Goossens, Tim Lammens, Maaike Van Trimpont, Annemieke Madder

Biomaterials Science · 2025 · 13 (15) · 4139-4152

DOI: 10.1039/d5bm00138b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2025. Verfasst von Hue Vu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Organic and Biomimetic Chemistry Research Group, Ghent University, 9000 Ghent, Belgium. annemieke.madder@ugent.be. Hauptthemen laut MEDLINE: Hydrogels, Asparaginase, Peptides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Kom op tegen Kanker, Universiteit Gent, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An injectable peptide hydrogel was used for the sustained release of Erwinase®, an FDA-approved therapeutic enzyme against acute lymphoblastic leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsAsparaginasePeptidesDelayed-Action PreparationsAnimalsHumansDrug LiberationMicePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Substanzen

HydrogelsAsparaginaseDelayed-Action PreparationsPeptides

Autor:innen und Institutionen

  • Organic and Biomimetic Chemistry Research Group, Ghent University, 9000 Ghent, Belgium. annemieke.madder@ugent.be.
  • Research Unit for Translational Research in Oncology, Department Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium. steven.goossens@ugent.be.
  • Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium.
  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium.
  • Research Group of Organic Chemistry, Vrije Universiteit Brussel, B-1050 Brussels, Belgium.

Förderung

  • Kom op tegen Kanker
  • Universiteit Gent
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Vu, H., Peeters, E., Hofkens, K., Vandemeulebroecke, K., T'Sas, S., Martin, C., Ballet, S., Hoogenboom, R., Goossens, S., Lammens, T., Van Trimpont, M., & Madder, A. (2025). Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels. Biomaterials Science, 13(15), 4139-4152. https://doi.org/10.1039/d5bm00138b

Vancouver

Vu H, Peeters E, Hofkens K, Vandemeulebroecke K, T'Sas S, Martin C, et al. Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels. Biomaterials Science. 2025;13(15):4139-4152. doi:10.1039/d5bm00138b

BibTeX
@article{Vu2025,
  author = {Vu, Hue and Peeters, Evelien and Hofkens, Kenneth and Vandemeulebroecke, Katrien and T'Sas, Sara and Martin, Charlotte and Ballet, Steven and Hoogenboom, Richard and Goossens, Steven and Lammens, Tim and Van Trimpont, Maaike and Madder, Annemieke},
  title = {Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels},
  journal = {Biomaterials Science},
  year = {2025},
  volume = {13},
  number = {15},
  pages = {4139--4152},
  doi = {10.1039/d5bm00138b}
}
Kostenlos starten →